S. Joseph Tarnowski, PhD

GlaxoSmithKline
Senior Vice President, R&D, Medicinal Science & Technology
Joseph Tarnowski, Ph.D., Senior Vice President of Cell and Gene Therapy Platforms, Medicinal Science & Technology, R&D at GSK. Experience in the research, development, registration and commercialization of products made using recombinant DNA technology. Earned a B.S. degree in Chemistry from Southeast Missouri State University, a Ph.D. degree in Biochemistry from the University of Tennessee Center for the Health Sciences and was a post-doctoral fellow at the Roche Institute of Molecular Biology. Held critical development roles for Roferon® A, Alpheron N®, Fiblast® Spray, CEPRATE® SC Stem Cell Concentration System, Natrecor®, Erbitux® Orencia®, Yervoy®, Nulojix®, Eperzan®/Tanzeum®, Nucala®, and Strimvelis™.